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Abstract
Background: Experimental studies suggest that systemic inflammation contributes to the pathophysiology of
delirium. The aim of our study was to determine blood-derived inflammatory signatures of post-stroke delirium.
Methods: We included 144 ischemic stroke patients. We assessed delirium on a daily basis during the first 7 days
of hospitalization. Venous blood was collected at day 3 after the onset of stroke and stimulated ex vivo with
lipopolysaccharide (LPS). We measured LPS-induced cytokine concentration (TNFα, IP-10, IL-1β, IL-6, IL-8, IL-10, and
IL-12p70) as well as plasma levels of IL-6 and TNFα.
Results: Delirium was diagnosed in 21.5% of patients. After correction for monocyte count, patients with delirium
had reduced LPS-induced TNFα, IP-10, IL-1β, IL-6, and IL-12 release. The plasma IL-6 level was higher in delirious
patients compared to patients without delirium. After adjusting for stroke severity and infections, higher ex vivo
TNFα (OR 0.29, 95%CI 0.11–0.72, P = 0.01), IP-10 (OR 0.25, 95%CI 0.08–0.73, P = 0.01), IL-1β (OR 0.42, 95%CI 0.20–0.89,
P = 0.02), and IL-12 (OR 0.07, 95%CI 0.01–0.70, P = 0.02) release was associated with the reduced risk of delirium.
In multivariate analysis, the higher plasma IL-6 was associated with the increased risk of delirium (OR 1.61, 95%CI
1.00–2.58, P = 0.04).
Conclusions: Reduced ex vivo release of pro-inflammatory cytokines after LPS stimulation and the elevated plasma
IL-6 are signatures of post-stroke delirium.
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Background
Delirium is a neuropsychiatric syndrome characterized by
acute, fluctuating changes in attention, awareness, and cog-
nition. Delirium is common among hospitalized elderly
people and is associated with increased mortality and poor
functional and cognitive outcome [1]. An estimated rate of
delirium after stroke is 26% with a range of 10 to 48% [2].
The pathophysiology of delirium is still poorly under-
stood. One of the current hypotheses of delirium suggests
that acute peripheral inflammation induces activation of
brain parenchymal cells and an expression of pro-
inflammatory mediators in the brain. These neuroinflam-
matory changes evoke a synaptic and neuronal dysfunction
and subsequent behavioral and cognitive symptoms [3–5].
The elderly and patients with neurodegenerative diseases
are particularly prone to develop delirium triggered by
systemic inflammation [3].
Although systemic inflammation is recognized as a trig-
ger of delirium, there is still limited evidence that links cir-
culating inflammatory mediators with delirium in humans.
The most replicated finding, albeit not confirmed by some
researchers, is the elevated blood interleukin (IL)-6 level
during delirium [6–9]. Other blood-based inflammatory
mediators which predicted delirium or were elevated
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during delirium in some studies include C-reactive protein
(CRP) [10, 11], IL-1β [12], IL-2 [9, 13], IL-8 [7], tumor
necrosis factor alpha (TNFα) [9, 13], and soluble TNFα
receptor 1 and 2 [12, 14].
Identification of blood-derived inflammatory signatures
of delirium is important for better understanding interac-
tions between the immune system and delirium and search-
ing of potential biomarkers of delirium. In this study, we
aimed to determine inflammatory signatures of post-stroke
delirium. Toll-like receptor 4 (TLR4) is a master regulator
of innate immunity. We assessed ex vivo cytokine release
after whole blood stimulation with lipopolysaccharide (LPS)
, an agonist of TLR4. For comparison, we measured plasma
levels of two cytokines: IL-6 and TNFα. We choose IL-6
because numerous studies demonstrated that the blood
level of this cytokine is elevated in acute stroke patients and
correlates with poor outcome [15]. Tumor necrosis factor
alpha was chosen, because a few studies showed an associ-
ated between this cytokine and post-stroke infections [16].
Methods
Patient selection and clinical assessment
The participants for this study were prospectively recruited
from stroke patients hospitalized in the Department of
Neurology, University Hospital, Krakow, Poland, between
October 2016 and June 2017. The inclusion criteria were as
follows: (1) ischemic stroke, (2) time from the onset of
stroke symptoms onset to admission < 24 h, (3) pre-stroke
modified Rankin Scale score 0–2 (independence in daily
activities), (4) National Institute of Health Stroke Scale
(NIHSS) score on admission > 3, and (5) informed patient
consent. The exclusion criteria were as follows: (1) chronic
inflammatory, autoimmune or cancerous diseases; (2)
coma; and (3) severe aphasia disabling the assessment of
delirium’s core features. Written informed consent was
obtained from each patient included in the study. The study
protocol conforms to the ethical guidelines of the 1975
Declaration of Helsinki. The study protocol was approved
by the Bioethics Committee of Jagiellonian University.
Since the main goal of our study was to determine
inflammatory signatures that are present during an episode
of delirium, we excluded patients in whom delirium oc-
curred before or after day 3 (i.e. the day of blood sampling),
but who had no delirium’s episode at day 3.
The diagnosis of pneumonia required the presence of
clinical findings (at least two from the following: productive
cough and/or purulent sputum, rales, fever, and
leukocytosis), as well as pulmonary infiltrates in chest X-
ray. Symptomatic urinary tract infection was diagnosed
based on one of the following two sets of criteria: (1) at
least one of the following signs is present: fever (> 38 °C),
urgency, dysuria, or suprapubic tenderness and positive
urine culture (≥ 105 microorganisms per cubic centimetre
with no more than two species of microorganisms), or (2)
at least one of the following signs is present: fever (> 38 °C),
urgency, dysuria, or suprapubic tenderness and at least two
of the following: positive dipstick for leukocyte esterase
and/or nitrate, pyuria (urine specimen with ≥ 10 white
blood cell/mm3), and organisms seen in Gram stains of
unspun urine [17].
Patients were screened for delirium on daily basis dur-
ing first 7 days after admission. Core features of delirium
were assessed using Brief Confusion Assessment Method
(bCAM) for verbal patients [18] and Intensive Care Units
version (CAM-ICU) for non-verbal patients [19]. The final
diagnosis of delirium was based on DMS-5 criteria [20].
The Informant Questionnaire on Cognitive Decline in
the Elderly (IQCODE) was used to diagnose a pre-stroke
cognitive decline [21]. IQCODE consists of 26 items that
rate the change in patients’ intellectual abilities over the
past 10 years. A cutoff of 3.3 was chosen to diagnose a
pre-stroke cognitive decline [22].
No formal protocol was used to treat delirium. In gen-
eral, management of delirium included early mobilization,
treatment of infections and pain, control of fluids and
electrolytes, and use of visual and hearing aids in patients
with sensory impairment. Neuroleptics were given only to
patients with severe agitation.
Laboratory assays
To avoid diurnal variation in cytokine production, blood
was obtained at day 3 after stroke rather than upon admis-
sion. Venous blood was collected in heparinized tubes
(Sarstedt, Germany) between 7:00 AM and 7:30 AM. The
whole blood was diluted by 1:5 in sterile RPMI 1640
medium supplemented with L-glutamine (Sigma Aldrich,
St. Louis, MO) and stimulated for 4 h at 37 °C and 5%CO2
with LPS (10 ng/mL, E. coli 0111:B4, Sigma Aldrich, St.
Louis, MO) in sterile tubes (Lonza, Walkersville, MD). The
supernatants were removed and stored at − 80 °C until
further analysis.
Similar to some previous studies [17, 23, 24], LPS-
induced cytokines were normalized for monocyte count,
because monocytes are the main producers of cytokines
after whole blood stimulation with endotoxin [25]. More-
over, normalization by monocyte count reduced the coef-
ficient of variation [26]. Taking into account the previous
publications [17, 23, 27] and our own preliminary experi-
ments on kinetics of cytokine release after whole blood
stimulation, a stimulation was performed for 4 h for TNFα
and interferon-gamma-inducible protein 10 (IP-10) and
24 h for interleukin(IL)-1β, IL-6, IL-8, IL-10, and IL-
12p70. TNFα and IP-10 concentration was measured
using commercially available ELISA kits from R&D
Systems (Minneapolis, MN). Concentration of IL-1β, IL-6,
IL-8, IL-10, and IL-12p70 was determined by a cytometric
bead array immunoassay (Human Inflammatory Kit, BD
Bioscience, San Diego, CA).
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Plasma level of TNFα and IL-6 was measured using
ELISA kits from R&D Systems (Minneapolis, MN).
Cytokine detection limits were 0.19 pg/mL for TNFα
and 0.11 pg/mL for IL-6.
Statistical analysis
The χ2 test was used to compare proportions, while the
Mann–Whitney U test was used to compare continuous
variables between groups. Logistic regression was used
to determine the predictors of functional outcome.
Distribution of cytokines was standardized to a mean 0
and standard deviation of 1. NIHSS score on admission
were put to a model as continuous variables. Variables
with P < 0.05 in univariate analysis were included in
multivariate analysis. The Box-Tidwell test was used to
check the linearity of the logit for the continuous inde-
pendent variables in logistic regression analysis. The
calculations were performed using the program STATIS-
TICA for Windows (version 12.5, Statsoft, Poland). The
calculated odds ratios are per standard deviation.
In additional analysis, we assessed an association
between raw values of LPS-induced cytokine (not nor-
malized for monocyte count) and delirium. We used the
receiver operating characteristic curves to find an opti-
mal cutoff level of cytokines that differentiates delirious
patients from non-delirious patients.
Results
We recruited 157 stroke patients. From final analysis,
we excluded patients who had no delirium at day 3
(i.e. the day of blood collection), but who developed
delirium before (N = 10) or after day 3 (N = 3).
The final cohort included 144 patients (median age 69,
IQs 63–79; 57.6% male). Delirium was diagnosed in 21.
5% of patients. Baseline characteristics of the patients
with delirium and the patients without delirium are
shown in Table 1.
Patients with delirium had more severe neurological
deficit on admission and more often suffered from pneu-
monia and urinary tract infection.
Compared to patients without delirium, delirious
patients exhibited reduced release of TNFα, IP-10, IL-
1β, IL-6, and IL-12 after whole blood stimulation with
LPS (Table 2). The plasma level of IL-6, but not TNFα,
was higher in patients with delirium.
The results of univariate analysis and multivariate ana-
lysis are shown in Table 3.
In univariate analysis, higher release of TNFα (OR 0.
19, 95%CI 0.09–0.41, P < 0.01), IP-10 (OR 0.13, 95%CI 0.
04–0.38, P < 0.01), IL-1β (OR 0.34, 95%CI 0.18–0.67, P <
0.01), IL-6 (OR 0.62, 95%CI 0.40–0.96, P = 0.03), and IL-
12 (OR 0.06, 95%CI 0.01–0.48, P = 0.01) was associated
with the reduced risk of delirium. Higher plasma IL-6
level was associated with the increased risk of delirium
(OR 2.77, 95%CI 1.53–5.04, P < 0.01).
An association between delirium and reduced release
of TNFα (OR 0.29, 95%CI 0.11–0.72, P = 0.01), IP-10
(OR 0.25, 95%CI 0.08–0.73, P = 0.01), IL-1β (OR 0.42,
95%CI 0.20–0.89, P = 0.02), and IL-12 (OR 0.07, 95%CI
0.01–0.70, P = 0.02) as well as the increased plasma IL-6
(OR 1.61, 95%CI 1.00–2.58, P = 0.04) remained
Table 1 Characteristics of patients with delirium and patients without delirium
Patients with delirium (N = 31) Patients without delirium (N = 113) P value
Age, median (IQs) 71 (64–80) 68 (63–79) 0.57
Male, n (%) 18 (58.1) 65 (57.5) 0.96
Hypertension, n (%) 24 (77.4) 82 (72.6) 0.59
Diabetes mellitus, n (%) 8 (25.8) 30 (26.5) 0.93
Atrial fibrillation, n (%) 13 (41.9) 32 (28.3) 0.15
Myocardial infarction, n (%) 5 (16.1) 14 (12.4) 0.58
Previous stroke, n (%) 3 (9.7) 14 (12.4) 0.68
IQCODE > 3.3, n (%)a 3/24 (12.5) 9/85 (10.6) 0.79
NIHSS score on admission, median (IQs) 17 (15–20) 7 (5–15) < 0.01
Pneumonia, n (%) 9 (29.0) 3 (2.6) < 0.01
Urinary tract infection, n (%)b 13/30 (43.3) 20/99 (20.2) 0.01
White blood cells count, × 103/μL, median (IQs) 11.7 (9.3–12.9) 8.3 (6.6–9.6) < 0.01
Monocyte count, × 103/μL, median (IQs) 1.1 (0.9–1.2) 0.8 (0.6–1.0) < 0.01
Intravenous thrombolysis, n (%) 20 (64.5) 64 (56.6) 0.43
Mechanical thrombectomy, n (%) 7 (22.6) 24 (21.2) 0.87
IQs interquartiles, IQCODE the Informant Questionnaire on Cognitive Decline in the Elderly
aData available for 109 patients
bData available for 129 patients
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significant after adjusting for stroke severity (NIHSS score
on admission), pneumonia, and urinary tract infection.
Finally, we analysed an association between delir-
ium and raw values of LPS-induced cytokine (not
normalized for monocyte count). Delirious patients
had reduced release of TNFα, IP-10, and IL-12 and in-
creased release of IL-8 compared to patients without delir-
ium (Table 2). In univariate analysis, TNFα < 2857.6 pg/mL
(OR 7.86, 95%CI 2.27–27.22, P < 0.01), IP-10 < 333.4 pg/mL
(OR 4.30, 95%CI 1.99–9.28, P < 0.01), IL-12 < 0.30 pg/mL
(OR 2.78, 95%CI 1.35–5.72, P < 0.01), IL-10 > 57.0 pg/mL
(OR 2.52, 95%CI 1.23–5.16, P = 0.01), and IL-8 > 1786.4 pg/
mL (OR 5.00, 95%CI 2.36–10.60, P < 0.01) were associated
with delirium. An association between delirium and TNFα
< 2857.6 pg/mL (OR 6.14, 95%CI 1.52–24.73 P = 0.01), IP-
10 < 333.4 pg/mL (OR 2.61, 95%CI 1.04–6.55, P = 0.04), IL-
10 > 57.0 pg/mL (OR 3.72, 95%CI 1.46–9.47, P = 0.01), and
IL-8 > 1786.4 pg/mL (OR 5.18, 95%CI 2.08–12.93, P < 0.01)
remained significant after adjusting for NIHSS score, pneu-
monia, and urinary tract infection.
Table 2 Cytokine levels in patients with delirium and patients without delirium
Patients with delirium (N = 31) Patients without delirium (N = 113) P value
Ex vivo stimulation
TNFα, pg/103 monocytes 1.76 (1.47–2.32) 3.17 (2.31–4.42) < 0.01
IP-10, pg/103 monocytes 0.17 (0.10–0.46) 0.56 (0.32–0.92) < 0.01
IL-1β, pg/103 monocytes 1.12 (0.62–1.78) 1.85 (1.26–2.61) < 0.01
IL-6, pg/103 monocytes 10.37 (8.55–14.52) 14.21 (9.81–18.16) 0.02
IL-12, pg/106 monocytes 0 (0–0) 1.46 (0–8.57) < 0.01
IL-10, pg/106 monocytes 66.58 (39.57–86.54) 59.70 (36.85–99.02) 0.82
IL-8, pg/103 monocytes 2.03 (1.51–2.93) 1.64 (1.08–2.56) 0.13
TNFα, pg/mL 2066 (1578–2550) 2404 (1555–3869) 0.03
IP-10, pg/mL 166.97 (108.45–366.40) 436.10 (201.28–797.10) < 0.01
IL-1β, pg/mL 1153 (680–1690) 1325 (1046–2092) 0.11
IL-6, pg/mL 10,455 (8885–16,362) 10,407 (7280–13,319) 0.41
IL-12, pg/mL 0 (0–0) 1.48 (0–6.91) < 0.01
IL-10, pg/mL 69.23 (36.67–103.38) 46.62 (31.99–72.11) 0.06
IL-8, pg/mL 2240 (1469–3209) 1279 (872–2055) < 0.01
Plasma
TNFα, pg/ml 0.91 (0.53–1.27) 0.70 (0.36–1.12) 0.09
IL-6, pg/mL 17.95 (7.09–46.75) 3.94 (2.21–7.29) < 0.01
Data are shown as medians with interquartiles
Table 3 Results of uni- and multivariate analysis
Univariate analysis Multivariate analysisa
Ex vivo stimulation
TNFα OR 0.19, 95%CI 0.09–0.41, P < 0.01 OR 0.29, 95%CI 0.11–0.72, P = 0.01
IP-10 OR 0.13, 95%CI 0.04–0.38, P < 0.01 OR 0.25, 95%CI 0.08–0.73, P = 0.01
IL-1β OR 0.34, 95%CI 0.18–0.67, P < 0.01 OR 0.42, 95%CI 0.20–0.89, P = 0.02
IL-6 OR 0.62, 95%CI 0.40–0.96, P = 0.03 OR 0.76, 95%CI 0.43–1.35, P = 0.35
IL-12 OR 0.06, 95%CI 0.01–0.48, P = 0.01 OR 0.07, 95%CI 0.01–0.70, P = 0.02
IL-10 OR 0.85, 95%CI 0.55–1.30, P = 0.44 OR 1.00, 95%CI 0.59–1.69, P = 0.99
IL-8 OR 1.15, 95%CI 0.80–1.66, P = 0.43 OR 1.34, 95%CI 0.80–2.24, P = 0.26
Plasma
TNFα OR 1.16, 95%CI 0.81–1.68, P = 0.41 OR 0.89, 95%CI 0.53–1.48, P = 0.64
IL-6 OR 2.77, 95%CI 1.53–5.04, P < 0.01 OR 1.61, 95%CI 1.00–2.58, P = 0.04
aAdjusted for NIHSS score on admission, pneumonia, and urinary tract infection
ORs are per standard deviation
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Discussion
We found reduced release of TNFα, IP-10, IL-1β, and
IL-12 after ex vivo blood stimulation and the elevated
plasma IL-6 level in delirious patients.
To our best knowledge, it is the first report showing
diminished ex vivo release of pro-inflammatory cytokines
in patients with delirium. This finding is consistent with
transient post-stroke immunodepression [28]. In acute
stroke patients, circulating monocytes exhibit an endo-
toxin tolerance status that manifests as the reduced TNFα
synthesis and the diminished HLA-DR expression after
LPS challenge [29]. An endotoxin tolerant state is a
phenomenon observed in patients with different patholo-
gies including sepsis, acute coronary syndrome, heart
failure, and cancer [30]. Endotoxin tolerance is a key
mechanism to limit an excessive innate reaction to
infection or injury. It was suggested that post-stroke
immunodepression is triggered by over-activation of the
sympathetic nervous system and the release of damage-
associated molecular patterns (DAMPs) [29, 31]. It would
be interesting to examine in future studies a relationship
between markers of autonomic nervous systems, circulat-
ing DAMPs and delirium.
Other mechanism which could be responsible for post-
stroke immunodepression is a release of high mobility
group box 1 (HMGB1) from the necrotic brain tissue to
blood. In vitro, extracellular HMGB1 induced endotoxin
tolerance in macrophages [32]. In the animal model of
cerebral ischemia, circulating HMGB1 acting via the
receptor of advanced glycation end-products (RAGE) was
responsible for the reduced secretion of TNFα and IL-12
by monocytes and lymphopenia [33]. A relationship
between delirium and circulating HMGB1 requires further
investigation.
We confirmed and extended previous studies examining
an association between IL-6 and delirium. IL-6 is the
strongest activator of the hepatic acute phase reaction,
and its blood levels are elevated in many infectious and
inflammatory diseases [34]. Higher blood levels of IL-6
were observed among delirious patients after cardiac
surgery [8], hip fracture [7], and major elective surgery [9]
as well as older patients acutely admitted to the hospital
[6]. In stroke patients, a source of circulating IL-6 seems
to be an ischemic brain or an adipose tissue [35].
In our study, plasma TNFα level did not differ signifi-
cantly between patients with delirium and patients without
delirium. The studies examining an association between
this cytokine and delirium yielded conflicting results. A few
studies reported the elevated level of circulating TNFα in
patients with post-operative delirium [9, 13] whereas other
studies did not find such as an association [7, 36].
The additional analysis of an association between values
of LPS-induced cytokine not normalized for monocyte
count and delirium revealed increased release of IL-8 and
IL-10 in delirious patients. Increased production of IL-10,
the prototypic anti-inflammatory cytokine, in delirious
patients supports an idea that post-stroke immunodepres-
sion is linked to delirium. Increased release of IL-8 after
blood stimulation with endotoxin is consistent with the
observation of elevated serum levels of IL-8 in elderly
patients with delirium after hip fracture [7].
Taking together, post-stroke delirium was associated
with both immunodepression and systemic inflammation
reflected by elevated circulating IL-6.
Our study has several limitations. Our results relied on
only single cytokine measurement. It remains unclear if
resolution of delirium is associated with any change in
cytokine synthesis. In this kind of study, pre-stroke ex vivo
cytokine synthesis and circulating cytokine level could not
be assessed. We cannot exclude a possibility that some of
our patients could have delirium only in the first hours of
stroke before admission. Our findings could not be gener-
alized on non-stroke patients with delirium and require
confirmation in different groups of delirious patients.
Conclusion
In conclusion, reduced ex vivo release of pro-inflammatory
cytokines after LPS stimulation and elevated plasma IL-6
are signatures of post-stroke delirium.
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